Division of Chest Medicine, Department of Internal Medicine, Yuanlin Christian Hospital, Changhua, Taiwan.
Department of Pathology, China Medical University Hospital, Taichung, Taiwan.
J Thorac Cardiovasc Surg. 2017 Jul;154(1):332-339.e1. doi: 10.1016/j.jtcvs.2017.02.059. Epub 2017 Mar 11.
The prognostic significance of the new classification of lung adenocarcinoma proposed in the 2015 World Health Organization guideline has been validated. This study aimed to compare the preoperative classification of the adenocarcinoma subtype based on computed tomography-guided 18-gauge core needle biopsy (CTNB) or radial probe endobronchial ultrasound (R-EBUS) specimens, with the postoperative classification based on the resected specimens.
We retrospectively analyzed a consecutive series of 128 patients (60 CTNB and 68 R-EBUS) who underwent surgery for preoperatively confirmed lung adenocarcinoma between 2010 and 2014. Comprehensive histological subtyping was performed according to the 2015 World Health Organization classification system. Diagnostic concordance of subtypes between small biopsy and resection specimens was assessed.
Concordant subtyping of adenocarcinomas between the predominant pattern on resections and biopsy sections was observed in 58.6% of cases (75 of 128; 95% confidence interval [CI], 49.9%-66.8%). Preoperative subtyping was accurate in only 30% of samples (3 of 10) with a predominance of solid patterns. None of the 5 micropapillary predominant cases was detected by CTNB or R-EBUS. For the concordance of the presence or absence of micropapillary/solid component, the sensitivity was as low as 16.5% (95% CI, 9.1%-26.5%). The detection rate by CTNB/R-EBUS increased with the increase in the percentage of micropapillary/solid component; however, even in the ≥40% micropapillary/solid group, only 24% of cases were detected by CTNB/R-EBUS.
The accuracy of the estimation of adenocarcinoma histological subtype based on preoperative biopsy sections was unsatisfactory.
2015 年世界卫生组织指南中提出的肺腺癌新分类的预后意义已经得到验证。本研究旨在比较基于 CT 引导 18 号针芯活检(CTNB)或径向探头支气管内超声(R-EBUS)标本的腺癌亚型术前分类与基于切除标本的术后分类。
我们回顾性分析了 2010 年至 2014 年间连续接受手术治疗的 128 例术前确诊为肺腺癌患者(CTNB 组 60 例,R-EBUS 组 68 例)的资料。根据 2015 年世界卫生组织分类系统进行全面组织学亚型分类。评估小活检和切除标本之间亚型的诊断一致性。
在 128 例患者中,58.6%(75/128;95%置信区间[CI],49.9%-66.8%)的患者在切除标本和活检切片上的主要模式一致。术前亚型在 10 个以实体模式为主的样本中只有 30%(3/10)准确。5 个微乳头为主的病例均未通过 CTNB 或 R-EBUS 检测到。对于微乳头/实体成分存在或不存在的一致性,敏感性低至 16.5%(95%CI,9.1%-26.5%)。CTNB/R-EBUS 的检出率随微乳头/实体成分百分比的增加而增加;然而,即使在微乳头/实体成分≥40%的组中,也只有 24%的病例通过 CTNB/R-EBUS 检测到。
基于术前活检切片对腺癌组织学亚型的估计准确性不理想。